Patient P-03482
Therapy response
Improving
Tolerance
Favorable
GI state
Deteriorating
Inflammatory state
Favorable
Nutritional resilience
Favorable
Discontinuation risk
31%
Trajectory
Baseline → today → 30-day prediction · hover a day for signals and eventssolid = observed · dashed = predicted
- Day 0 ONX-7 started — Baseline state S05
- Day 44 AD-05 recommended — Adherence Support AD-05
- Day 45 Patient accepted — Started AD-05 in the companion
- Day 50 No meaningful change — Adherence Support AD-05
What changed?
Trajectory is tracking the baseline prediction.
Primary contributors, last 14 days
- GI instability+11
What helped?
- Adherence Support AD-05Day 44Result: no meaningful change
LIFE OS recommendation
No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.
Daily trackers
Molecule settingsThe trackers this program marks as important, last 14 days vs the 14 before.
Energy level
Daily log5.6/10
improving · +0.6 vs previous 14 d
Stress level
Daily log4.5/10
improving · -0.8 vs previous 14 d
Pessimism score
Daily log3.7/10
improving · -0.7 vs previous 14 d
Sleep quality
Wearable18.2/100
improving · +5.1 vs previous 14 d
Libido
Daily log4.2/10
improving · +0.7 vs previous 14 d
HRV
Wearable30.4 ms
improving · +2.5 vs previous 14 d
Toxicity
Blood19.8/100
improving · -5.1 vs previous 14 d
This trajectory is doing well — what to keep, what to watch
Steering view →Heading towards restoration · 76 from the failing basin, 12 from restoration.
Good elements to keep
- Adherence Support AD-05intervention · steering +8.1
- Butyrate producers intacthidden · steering +7.5
- Protein (supports)perturbation · steering +7.1
- Proteinsupporter · GI -3.7 next day
Main detractors to watch
- Alcoholperturbation · steering -4.6
- Poor-sleep weekperturbation · steering -3
- Low-HRV stretchperturbation · steering -2.7
- Dietary driftperturbation · steering -2.6
- Alcoholdetractor · GI +2.8 next day
State influencers · digestive
Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.
- Protein-3.7supporter · 95%
- Alcohol+2.8detractor · 95%
- Histamine load-1no signal · 23%
- Dietary fat load-0.7no signal · 16%
- Lactose+0.7no signal · 17%
- Caffeine0no signal · 15%
Biological layers
Which pathways look influenced, and by which layer of this person's biology.
Pathways under pressure
- Butyrate / short-chain fatty acid production ↓25
- MicrobiomeF. prausnitzii depleted
- Autonomic recovery ↓20
- WearableShort sleep window
- Inflammatory signalling ↓15
- WearableHRV 30 ms, trending down
- Mucosal barrier integrity ↓10
- WearableSleep 5.6 h, below personal baseline
DNA
Fictional pharmacogenomic panel
- CYP2D6 Normal metabolizerExpected exposure
- MTHFR C677TReduced folate turnover
Microbiome
Shannon diversity 4.5 · butyrate capacity 72/100
- Akkermansia muciniphilaNormal
- Faecalibacterium prausnitziiLow
- Bacteroides fragilisNormal
- Bifidobacterium longumLow
- EnterobacteriaceaeNormal
Wearable, last 14 days
daily evolution fed into the runtime
- HRV
- 33 ms
- Sleep
- 6.0 h
- Steps
- 5,959
- Resting HR
- 65 bpm
Daily log: GI score 24, nutritional resilience 66, adherence 91.
What this patient sees in NostraAI
The content that steers the trajectory: what to eat, what to do, what to take.
What to eat
- Keep meals regular; three to four moderate portions spaced through the day
- Include a cooked vegetable portion with each main meal
- Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
- Avoid known triggers for now: fried or oily food, dairy, alcohol
What to do
- Log the daily check-in; one line is enough
- Keep the current walking rhythm
- Protect a 7.5-hour sleep window; screens off 30 minutes before
- Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
- Take the scheduled dose as agreed with your care team
- No additional supplements this week
- Fictional demo item: continue vitamin D as before
284 biologically similar trajectories
Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.